Research Reports

Healthcare

icon
Home » Reports » Immunotherapy Drug Market Global Demand Analysis Opportunity Outlook 2021
Market Research Report

Immunotherapy Drug Market : Global Demand Analysis & Opportunity Outlook 2021

Published On : 11:07 PM, 30th October, 2017 REP-ID-60 Category: Healthcare

Immunotherapy also referred as biologic therapy is a kind of treatment which is designed to enhance human immunity system to fight against cancer. Immunotherapy restores or improves immunity system to restrict growth of cancer cells, preventing it to spread to other parts of the body and also enables the immunity system to destroy cancer cells from the body.   

Global Immunotherapy Drug market is envisioned to exhibit a compound annual growth rate (CAGR) of 13.0% during 2015-2021.

Market Segmentation

By Drug Types

Based on types, global Immunotherapy Drug market can be segmented into:

  • Antibodies
  • Interleukins
  • Interferon
  • Checkpoint Inhibitors
  • Vaccines

By Region

Geographically, global Immunotherapy Drug market is segmented into North America, Latin America, Western and Eastern Europe, Asia-Pacific, Middle East and North Africa (MENA) and Rest of world.

Growth Drivers and challenges

Rising incidences of cancer across the globe coupled with increasing inclination towards cancer treatments with lesser side effects are believed to augment the growth of global immunotherapy drug market in future.

In addition to that, escalation of approval process in cancer related drugs is also expected to drive the global immunotherapy drug market over the forecast period i.e. 2015-2021.

However, high cost associated with immunotherapy devices along with lack of awareness of biologic cancer therapy is anticipated to hamper the growth of global immunotherapy drug market over next few years.

Market Size and Forecast

North America is believed to hold the first rank in global immunotherapy drug market during 2015-2021. It is projected that in 2016, 1.7 million new cancer cases would be detected in the U.S., making the country a major market for immunotherapy drugs in North America. The immunotherapy drug market in the region is also believed to spurt from higher spending on health care sector.

Western Europe immunotherapy drug market is also expected to witness a promising growth sparked by rising cases of lung cancer, which is responsible for 215 of all cancer mortalities in the European region.

Asia-Pacific immunotherapy drug market is likely to behold the highest CAGR during the forecast period i.e. 2015-2021. Rising per capita income and increasing investments on healthcare infrastructure are some of the major factors which are projected to bolster Immunotherapy Drug market in countries such as India and China.

Key Players

Global Immunotherapy Drug market includes some of the major players such as AbbVie Inc., Amgen Inc., Novartis International Ag, F. Hoffmann-La Roche Ltd, Merck, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Johnson & Johnson Services Inc, AstraZeneca plc, Pfizer Inc.

Scope and Context

Overview of the Parent Market

Analyst View

Market Size and Growth

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia Poland, Rest of Eastern Europe)
  • Asia-Pacific (China, India, Singapore, Japan, Australia & New Zealand & Rest of Asia)
  • Middle East and North Africa (MENA)
  • Rest of World

Segmentation

  • By Type
  • By Region

Market Dynamics

Supply & Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment

key Answers

SELECT LICENSE TYPE

    • "This is an ongoing research and would be delivered in next 15-20 days."
    • Pre-Book now and get receive 10% discount.

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Request for Toc

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

Ask The Analyst

Delivery Center

1014, 10th Floor, Tower A1,
Ansal Corporate Park, Plot no 7A/1,
Sector 142 Noida., 201301 India
Phone : +91 958 228 3827, +91 120 660 5495
info@researchnester.com

US Office

1820 Avenue M, Suite# 1113,
Brooklyn, New York 11230
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com

UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Copyright © 2017 Research Nester. All rights reserved

Top